Wilmington, NC - Prestige Scientific is excited to announce the successfully completed search for a Fractional Chief Medical Officer with our partner, an early-stage RNA company initially developing therapies for neurodegenerative diseases.
The individual hired for this interim role brings more than twenty years of drug discovery and development experience with a successful track record in advancing new therapies to the clinic for several neurodegenerative diseases, as well as Phase I-IV clinical trial experience. They have significant experience with regulatory agencies in the US, Canada, and EU for key milestones regarding the development of small molecules and mRNA therapies.
Prestige Scientific presented the hired candidate on the first day of the search and completed the project in 18 days. Congratulations to Shawn Friend and Tricia Krzywicki for this successful search.
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
